Biodexa Pharmaceuticals (BDRX) Operating Leases (2018 - 2025)
Biodexa Pharmaceuticals' (BDRX) quarterly Operating Leases came in at $81140.1 in Q4 2025, down 64.68% year-over-year from $229746.8 in Q4 2024, and down 64.68% quarter-over-quarter from $229746.8 in Q4 2024.
Analysis
Biodexa Pharmaceuticals (BDRX) Operating Leases (2018 - 2025) Analysis & Trends
Biodexa Pharmaceuticals has disclosed Operating Leases across 8 years of filings, most recently posting $81140.1 for Q4 2025.
- In Q4 2025, Operating Leases fell 64.68% year-over-year to $81140.1; the TTM figure through Dec 2025 stood at $81140.1 (down 64.68% YoY), while the FY2025 annual figure was $80429.1, down 64.85% from the prior year.
- Operating Leases came in at $81140.1 for Q4 2025 at Biodexa Pharmaceuticals, down from $229746.8 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $745449.9 in Q4 2021 to a low of $81140.1 in Q4 2025.
- Average Operating Leases over 5 years is $290986.6, with a median of $209754.7 recorded in 2023.
- Year-over-year, Operating Leases plunged 74.67% in 2022 and gained 11.07% in 2023.
- Over 5 years, Operating Leases stood at $745449.9 in 2021, then sank by 74.67% to $188841.5 in 2022, then climbed by 11.07% to $209754.7 in 2023, then rose by 9.53% to $229746.8 in 2024, then sank by 64.68% to $81140.1 in 2025.
- Per Business Quant data, the three most recent Operating Leases figures were $81140.1 in Q4 2025, $229746.8 in Q4 2024, and $209754.7 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.24 Bn | 192.25 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.01 Bn | 176.83 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.33 Bn | 123.47 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.87 Bn | 73.87 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.27 Bn | 55.08 Bn | 1.37 Bn |
| 6 | Moderna | 53.93 Bn | 48.79 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.17 Bn | 29.86 Bn | 992.69 Mn |
| 8 | Biogen | 31.89 Bn | 30.60 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn |
| 10 | Biodexa Pharmaceuticals | 51.14 Mn | 39.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 81,140.14 |
| Dec 31, 2024 | 229,746.83 |
| Dec 31, 2023 | 209,754.67 |
| Dec 31, 2022 | 188,841.46 |
| Dec 31, 2021 | 745,449.87 |
| Dec 31, 2020 | 2.06 Mn |
| Dec 31, 2019 | 853,721.34 |
| Dec 31, 2018 | 321,691.81 |